- Recommendation ID
- NG230/03
- Question
Active surveillance compared with surgery: For people with stage 1 differentiated thyroid cancer, what is the clinical and cost effectiveness of active surveillance compared with surgery?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on surgery and active surveillance for primary tumours.
Full details of the evidence and the committee's discussion are in evidence review H: initial treatments for differentiated thyroid cancer.
Source guidance details
- Comes from guidance
- Thyroid cancer: assessment and management
- Number
- NG230
- Date issued
- December 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/12/2022 |